Serum cystatin C is related to pulse wave velocity even in subjects with normal serum creatinine

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1895-1902

  Song, Sang Heon ^a   Kwak, Ihm Soo ^a   Kim, Young Joo ^a   Lee, Hee Sun ^a   Rhee, Harin ^a   Lee, Dong Won ^a   Kang, Yang Ho ^a   Kim, Seong Jang ^a  

^a Pusan National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; INSULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ANKLE BRACHIAL PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PULSE WAVE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; BLOOD FLOW VELOCITY; HYPERTENSION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PULSATILE FLOW; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CREATININE; CYSTATIN C; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULSATILE FLOW; REGRESSION ANALYSIS; SEX FACTORS; YOUNG ADULT;

EID: 58149382053     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1895     Document Type: Article

References (24)

1. Shlipak MG, PrauNht ML, Sarnak MJ: Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens 2006; 15: 270-275.
2. Grubb AO: Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000; 35: 63-99.
3. Simonsen O, Grubb A, Thysell H: The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration. Scand J Clin Lab Invest 1985; 45: 97-101.
4. Koenig W, Twardella D, Brenner H, Rothenbacher D: Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clin Chem 2005; 51: 321-327.
5. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L: Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004; 110 2342-2348.
6. Shlipak MG, Katz R, Fried LF, et al: Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005; 45 268-271.
7. Maahs DM, Ogden LG, Kretowski A, et al: Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes. Diabetes 2007; 56: 2774-2779.
8. Boutouyrie P, Tropeano AI, Asmar R, et al: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002; 39: 10-15.
9. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241
10. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-2090.
11. Yamashina A, Tomiyama H, Takeda F, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. Ohya Y, Iseki K, Iseki C, Miyagi T, Kinjo K, Takishita S: Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis 2006; 47: 790-797.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
14. Levy AS, Greene T, Kusek J, Beck GJ, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828 (Abstract).
15. Perkins BA, Nelson RG, Ostrander BE, et al: Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16: 1404-1412.
16. LaterzA OF, Price CP, Scott MG: Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48: 699-707.
17. Shlipak MG, Sarnak MJ, Katz R, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
18. Shlipak MG, Katz R, Cushman M, et al: Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005; 118: 1416.e25-1416.e31.
19. Bengtsson E, To F, Håkansson K, et al: Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25: 2151-2156.
20. Knight EL, Verhave JC, Spiegelman D, et al: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421.
21. Safar ME, London GM, Plante GE: Arterial stiffness and kidney function. Hypertension 2004; 43: 163-168.
22. Blacher J, Demuth K, Gurerin AP, Safar ME, Moatti N, London GM: Influence of biomedical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535-541.
23. Benetos A, Waeber B, Izzo J, et al: Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002; 15: 1101-1108.
24. Song SH, Kwak IS, Kim YJ, et al: Can gamma-glutamyl-transferase be an additional marker of arterial stiffness? Circ J 2007; 71: 1715-1720.